Financials

  • Market Capitalization 706.54 M
  • Employee 106
  • Founded 2016
  • CEO N/A
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG01L3GYF02
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.02
Relación precio/flujo de caja
0.18

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2677
AURA
Aura Biosciences, Inc. - Common Stock
7.00 USD0.00%-0.43%+9.03%+6.71%723.71 M USD
2679
CADL
Candel Therapeutics, Inc. - Common Stock
9.87 USD+2.39%+2.49%+16.39%+55.92%723.18 M USD
2723
MNPR
Monopar Therapeutics Inc. - Common Stock
99.79 USD-3.43%+6.31%+64.64%+82.70%668.50 M USD
2737
TECX
Tectonic Therapeutic, Inc. - Common Stock
34.81 USD+1.37%-4.13%+17.96%+102.97%656.84 M USD